Clinical Trial Update: CS-101 in Patients With β-thalassemia [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 clinical trial update for CS-101 in patients with Beta-thalassemia; recruitment is ongoing by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia

Drugs mentioned

• CS-101

Snippet

Sponsor: CorrectSequence Therapeutics Co., Ltd | Conditions: Beta-Thalassemia | EARLY_Phase 1 | Status: ENROLLING_BY_INVITATION